Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Receivables - Other (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Receivables - Other for 8 consecutive years, with $40.9 million as the latest value for Q1 2026.

  • For Q1 2026, Receivables - Other fell 11.44% year-over-year to $40.9 million; the TTM value through Mar 2026 reached $40.9 million, down 11.44%, while the annual FY2025 figure was $35.6 million, 0.15% changed from the prior year.
  • Receivables - Other hit $40.9 million in Q1 2026 for Bicycle Therapeutics, up from $35.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $67.3 million in Q3 2025 and bottomed at $12.9 million in Q2 2023.
  • Average Receivables - Other over 5 years is $35.0 million, with a median of $35.6 million recorded in 2024.
  • Year-over-year, Receivables - Other dropped 20.81% in 2023 and then surged 260.47% in 2024.
  • Bicycle Therapeutics' Receivables - Other stood at $19.2 million in 2022, then increased by 25.45% to $24.0 million in 2023, then skyrocketed by 48.31% to $35.7 million in 2024, then decreased by 0.15% to $35.6 million in 2025, then increased by 14.94% to $40.9 million in 2026.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $40.9 million, $35.6 million, and $67.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.